These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24056726)

  • 1. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent.
    Wu X; Lindner D; Yu GP; Brady-Kalnay S; Lu ZR
    J Vis Exp; 2013 Sep; (79):. PubMed ID: 24056726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.
    Wu X; Burden-Gulley SM; Yu GP; Tan M; Lindner D; Brady-Kalnay SM; Lu ZR
    Bioconjug Chem; 2012 Aug; 23(8):1548-56. PubMed ID: 22812444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
    Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
    Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.
    Tan M; Ye Z; Lindner D; Brady-Kalnay SM; Lu ZR
    Pharm Res; 2014 Jun; 31(6):1469-76. PubMed ID: 23471641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging.
    Tan M; Wu X; Jeong EK; Chen Q; Lu ZR
    Biomacromolecules; 2010 Mar; 11(3):754-61. PubMed ID: 20131758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.
    Tan M; Wu X; Jeong EK; Chen Q; Parker DL; Lu ZR
    Mol Pharm; 2010 Aug; 7(4):936-43. PubMed ID: 20481565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.
    Ye F; Wu X; Jeong EK; Jia Z; Yang T; Parker D; Lu ZR
    Bioconjug Chem; 2008 Dec; 19(12):2300-3. PubMed ID: 19053180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
    Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
    Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
    Lu ZR; Laney V; Li Y
    Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
    Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR
    Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
    Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
    Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
    Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
    Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
    Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.
    Port M; Corot C; Rousseaux O; Raynal I; Devoldere L; Idée JM; Dencausse A; Le Greneur S; Simonot C; Meyer D
    MAGMA; 2001 May; 12(2-3):121-7. PubMed ID: 11390267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naphthalene-facilitated self-assembly of a Gd-chelate as a novel
    Zhang Y; Zhang H; Huang D; Tan B; Zhang C; Deng Z
    J Mater Chem B; 2021 Jul; 9(28):5729-5737. PubMed ID: 34231635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.
    Demine S; Balhuizen A; Debaille V; Joosten L; Fereau M; Chilla SNM; Millard I; Scharfmann R; Egrise D; Goldman S; Marchetti P; Gotthardt M; Laurent S; Burtea C; Eizirik DL
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30134599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay of T1- and T2-relaxation on T1-weighted MRI of hMSCs induced by Gd-DOTA-peptides.
    Cao L; Li B; Yi P; Zhang H; Dai J; Tan B; Deng Z
    Biomaterials; 2014 Apr; 35(13):4168-74. PubMed ID: 24560458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
    Delrue LJ; Casneuf V; Van Damme N; Blanckaert P; Peeters M; Ceelen WP; Duyck PC
    MAGMA; 2011 Aug; 24(4):225-32. PubMed ID: 21567161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm.
    Heckl S; Debus J; Jenne J; Pipkorn R; Waldeck W; Spring H; Rastert R; von der Lieth CW; Braun K
    Cancer Res; 2002 Dec; 62(23):7018-24. PubMed ID: 12460922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).
    Goswami LN; Ma L; Cai Q; Sarma SJ; Jalisatgi SS; Hawthorne MF
    Inorg Chem; 2013 Feb; 52(4):1701-9. PubMed ID: 23391150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.